Citation: | Qi Liang, Bo Qu, Chunye Li, Yue Hu, Chunyi Yang, Tingting Yang, Yuzhu Di, Hui Li. Clinical characteristics and north-south differences of inflammatory bowel disease in China: A cross-sectional study and meta-analysis[J]. Frigid Zone Medicine, 2024, 4(1): 23-30. doi: 10.2478/fzm-2024-0003 |
[1] |
Roda G, Chien Ng S, Kotze P G, et al. Crohn's disease. Nat Rev Dis Primers, 2020; 6(1): 22. doi: 10.1038/s41572-020-0156-2
|
[2] |
Ungaro R, Mehandru S, Allen P B, et al. Ulcerative colitis. Lancet, 2017; 389(10080): 1756-1770. doi: 10.1016/S0140-6736(16)32126-2
|
[3] |
Ng S C, Shi H Y, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet, 2017; 390(10114): 2769-2778. doi: 10.1016/S0140-6736(17)32448-0
|
[4] |
Kaplan G G. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol, 2015; 12(12): 720-727. doi: 10.1038/nrgastro.2015.150
|
[5] |
Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives - PubMed[EB/OL]. /2023-03-25.
|
[6] |
The differences between American and Chinese patients with Crohn's disease - PubMed[EB/OL]. /2023-03-25.
|
[7] |
Ng S C, Kaplan G G, Tang W, et al. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific. Am J Gastroenterol, 2019; 114(1): 107-115. doi: 10.1038/s41395-018-0233-2
|
[8] |
Zhao J, Ng S C, Lei Y, et al. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease. Inflamm Bowel Dis, 2013; 19(9): 1839-1845. doi: 10.1097/MIB.0b013e31828a6551
|
[9] |
Zeng Z, Zhu Z, Yang Y, et al. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: A prospective population-based study: incidence of inflammatory bowel disease. J Gastroenterol Hepatol, 2013; 28(7): 1148-1153. doi: 10.1111/jgh.12164
|
[10] |
Yang H, Li Y, Wu W, et al. The incidence of inflammatory bowel disease in northern China: a prospective population-based study. PLoS ONE, 2014; 9(7): e101296. doi: 10.1371/journal.pone.0101296
|
[11] |
Ng S C, Tang W, Ching J Y, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology, 2013; 145(1): 158-165. e2. doi: 10.1053/j.gastro.2013.04.007
|
[12] |
Baiping Zhang. Ten scientific issues in the study of north-south transition zone in China. Advances in Geographical Sciences, 2019; 38(3): 305-311.
|
[13] |
Borenstein M, Hedges L V, Higgins J P T, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods, 2010; 1(2): 97-111. doi: 10.1002/jrsm.12
|
[14] |
Kaplan G G, Ng S C. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology, 2017; 152(2): 313-321. e2. doi: 10.1053/j.gastro.2016.10.020
|
[15] |
Goodman W A, Erkkila I P, Pizarro T T. Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol, 2020; 17(12): 740-754. doi: 10.1038/s41575-020-0354-0
|
[16] |
Park S-K, Wong Z, Park S H, et al. Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study. Dig Liver Dis, 2021; 53(2): 196-201. doi: 10.1016/j.dld.2020.06.046
|
[17] |
Park S H, Kim Y-J, Rhee K H, et al. A 30-year trend analysis in the epidemiology of inflammatory bowel disease in the Songpa-Kangdong District of Seoul, Korea in 1986-2015. J Crohns Colitis, 2019; 13(11): 1410-1417. doi: 10.1093/ecco-jcc/jjz081
|
[18] |
Nguyen G C, Chong C A, Chong R Y. National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States. J Crohns Colitis, 2014; 8(4): 288-295. doi: 10.1016/j.crohns.2013.09.001
|
[19] |
Zhao M, Gönczi L, Lakatos P L, et al. The burden of inflammatory bowel disease in europe in 2020. J Crohns Colitis, 2021; 15(9): 1573-1587.
|
[20] |
Jones G R, Lyons M, Plevris N, et al. IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology. Gut, 2019; 68(11): 1953-1960. doi: 10.1136/gutjnl-2019-318936
|
[21] |
Nerich V, Monnet E, Weill A, et al. Fine-scale geographic variations of inflammatory bowel disease in France: correlation with socioeconomic and house equipment variables. Inflamm Bowel Dis, 2010; 16(5): 813-821. doi: 10.1002/ibd.21122
|
[22] |
Nerich V, Monnet E, Etienne A, et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis, 2006; 12(3): 218-226. doi: 10.1097/01.MIB.0000206540.38834.8c
|
[23] |
Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut, 1996; 39(5): 690-697. doi: 10.1136/gut.39.5.690
|
[24] |
Soon I S, Molodecky N A, Rabi D M, et al. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC gastroenterol, 2012; 12: 51. doi: 10.1186/1471-230X-12-51
|
[25] |
Prideaux L, Kamm M A, De Cruz P P, et al. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol, 2012; 27(8): 1266-1280. doi: 10.1111/j.1440-1746.2012.07150.x
|
[26] |
Myles I A. Fast food fever: reviewing the impacts of the Western diet on immunity. Nutr J, 2014; 13: 61. doi: 10.1186/1475-2891-13-61
|
[27] |
Cabré E, Domènech E. Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J Gastroenterol, 2012; 18(29): 3814-3822. doi: 10.3748/wjg.v18.i29.3814
|
[28] |
Mak W Y, Zhao M, Ng S C, et al. The epidemiology of inflammatory bowel disease: East meets west. J Gastroenterol Hepatol, 2020; 35(3): 380-389. doi: 10.1111/jgh.14872
|
[29] |
Crohn's disease of esophagus, stomach and duodenum - PubMed[EB/OL]. /2023-03-26.
|
[30] |
Oral and upper gastrointestinal Crohn's disease - PubMed[EB/OL]. /2023-03-26.
|
[31] |
Sun X W, Wei J, Yang Z, et al. Clinical Features and Prognosis of Crohn's Disease with Upper Gastrointestinal Tract Phenotype in Chinese Patients. Dig Dis Sci, 2019; 64(11): 3291-3299. doi: 10.1007/s10620-019-05651-1
|
[32] |
Zhao M, Gönczi L, Lakatos P L, et al. The Burden of Inflammatory Bowel Disease in Europe in 2020. J Crohns Colitis, 2021; 15(9): 1573-1587. doi: 10.1093/ecco-jcc/jjab029
|
[33] |
Wang Y, Ouyang Q, APDW 2004 Chinese IBD working group. Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients. J Gastroenterol Hepatol, 2007; 22(9): 1450-1455. doi: 10.1111/j.1440-1746.2007.04873.x
|
[34] |
Wang Y F, Zhang H, Ouyang Q. Clinical manifestations of inflammatory bowel disease: East and West differences. J Dig Dis, 2007; 8(3): 121-127. doi: 10.1111/j.1443-9573.2007.00296.x
|
[35] |
Filmann N, Rey J, Schneeweiss S, et al. Prevalence of Anemia in Inflammatory Bowel Diseases in European Countries: A Systematic Review and Individual Patient Data Meta-analysis. Inflamm Bowel Dis, 2014; 20(5): 936-945. doi: 10.1097/01.MIB.0000442728.74340.fd
|
[36] |
Ds L, Kb B, Jy K, et al. The prevalence and clinical characteristics of anemia in Korean patients with inflammatory bowel disease. Intest Res, 2016; 14(1): 43-49. doi: 10.5217/ir.2016.14.1.43
|
[37] |
Antunes C V de A, Hallack Neto A E, Nascimento C R de A, et al. Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology. Biomed Res Int, 2015; 2015: 728925. doi: 10.1155/2015/728925
|
[38] |
Vavricka S R, Rogler G, Gantenbein C, et al. Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the swiss inflammatory bowel disease cohort. Inflamm Bowel Dis, 2015; 21(8): 1794-1800. doi: 10.1097/MIB.0000000000000429
|
[39] |
Marin-Jimenez I, Bastida G, Forés A, et al. Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study. BMJ open gastroenterol, 2020; 7(1): e000351. doi: 10.1136/bmjgast-2019-000351
|
fzm-4-1-23_ESM.pdf |